Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPY5R | FIMM | pan-cancer | AAC | 0.49 | 0.003 |
mRNA | ARL15 | FIMM | pan-cancer | AAC | 0.49 | 0.002 |
mRNA | ZNF510 | FIMM | pan-cancer | AAC | 0.5 | 0.003 |
mRNA | ATRNL1 | FIMM | pan-cancer | AAC | 0.5 | 0.002 |
mRNA | MOSPD2 | FIMM | pan-cancer | AAC | 0.5 | 0.003 |
mRNA | INPP4B | FIMM | pan-cancer | AAC | 0.51 | 0.002 |
mRNA | JAK2 | FIMM | pan-cancer | AAC | 0.52 | 0.003 |
mRNA | PGM5 | FIMM | pan-cancer | AAC | 0.52 | 0.001 |
mRNA | SLC19A2 | FIMM | pan-cancer | AAC | 0.52 | 0.002 |
mRNA | PARD6B | FIMM | pan-cancer | AAC | 0.53 | 0.001 |